It’s our pleasure to announce the next and last VentureClass of 2019 on Thursday evening 28 November by Marc Wesselink, who will talk about funding, and the top 3 biggest mistakes you can make!
Marc is a serial entrepreneur who started 12 companies between 1994 and 2008 and invested in over 150 between 2004 and 2018. His purpose in life is to help as many entrepreneurs become successful founders of companies which can create an impact. He is active in Europe & Africa.
As one of the founding partners of Startupbootcamp, he was part of the global roll out and recruited over 160 companies for the Amsterdam & Cape Town programs and have helped them raised over 150 MIO EUR funding. He was responsible of managing the portfolio of Startupbootcamp with a value of over 500 MIO EUR.
Since October 2018 he started his next challenge since the investment landscape in Europe & Africa is still in need of one: How to improve investment in Pre-Seed, Seed & Early Stage companies. He has created an entire digital way of investing in early stage companies at large scale and de-risk it at the same time. The platform will be capable in investing > 150 companies a year by using automated processes and follow on investment based on real time data. The fund will also offer execution power with a network of experienced professionals who will help single founders, founder teams & corporates to start & scale a company.
Join us in November to hear more about Marc and the do’s and don’ts in funding – and the following networking drinks!
07:30 p.m.: Welcome & Introduction by Aard Groen
07:45 p.m.: VentureClass by Marc Wesselink
09:00 p.m.: Networking drinks:
It’s our pleasure to announce the first VentureClass of 2020 on Thursday evening 23 January by Ronald Apeldoorn and Robin Spelbrink of Avebe.
Avebe is a cooperative of starch-potato growers focused on the market. Traditionally the focus was on extracting starch from potatoes. However, by developing innovative methods Avebe now also extracts proteins from potatoes that are intended for the food industry. But there is more…. A potato is a source of opportunities with even more ingredients that can be turned into value. In other words, if it’s in there, Avebe will extract it! Every day 1,350 Avebe employees work on using all the opportunities provided by potatoes to make life pleasanter, healthier and more convenient – for clients, members, and society as a whole.
In this VentureClass you have the opportunity to learn more about Avebe as a company, their innovative projects, and one project in particular: In addition to starch, the potato tuber also contains protein, which in the tuber serves as a nitrogen storage, defense mechanism against food and as enzymes to catalyze the metabolism. When the protein fraction of the potato is extracted via mild processes, the enzymatic action of the protein is retained. It appears that a large part of the enzyme fraction of the potato consists of lipase, and this lipase can be used not only to hydrolyze ester bonding but also to synthesize it. Under water-poor conditions, potato lipase appears to be able to form esters from fatty acids and small alcohols, thereby forming biodiesel. Avebe has filed a patent on this and has made this patent available to VentureWeb and IHOG to set up and work out a business case for this.
Join us to hear more about Avebe – and the following networking drinks on January 23!
It’s our pleasure to announce the next VentureClass of 2020 on Thursday evening 27 February by VentureLab alumn Ludo van Hijfte of Fizzy Transitions.
Fizzy Transition Ventures delivers solutions for a smooth transition to a sustainable world by building on the foundations of our current infrastructure. We are front runners in building the “carbon capture and storage (CCS)” chain by developing the world’s first CO2 transportation system over water that delivers directly to depleted offshore gas fields. In parallel we are designing super-diversity “ECO-Reefs” on existing offshore structures that help restore the marine environment and can support both eco-tourism and local communities.
Ludo van Hijfte
Ludo van Hijfte (50) has enjoyed a varied career after graduating from McGill University with a degree in Mining Engineering. He started as an engineer with a Canadian mining company, became a research analyst with a Canadian investment bank and subsequently spent 15 years at Shell where he gained experience in various roles in the fields of corporate strategy, portfolio management, business planning, economics and new business development. He is Managing Director of Fizzy Transition Ventures which he founded in 2017.
Join us for the VentureClass to learn more about the divers and exciting things happening at Fizzy Transitions!
07:30 p.m.: Welcome & Introduction by Aard Groen
07:45 p.m.: VentureClass by Ludo van Hijfte
09:00 p.m.: Networking drinks
In the Netherlands alone nearly 3 million people live with chronic pain. A huge potential market. One that Reducept founders Louis Zantema and Margryt Fennema are taking by storm. Reducept is a virtual reality training for chronic pain treatment. With chronic pain, using medication might not be your favorite solution. The good thing is, you brain can be trained to decrease the pain itself. All the pain you feel, is made in the brain. The Reducept Method focusses directly at the brain. As a patient a person can train their brain to send out less pain signals, and experience less pain. The Reducept Method functions like a gym for the brain, without having to leave home. By exercising regularly, a person can teach their brain to increase control and reduce pain. Train towards a ‘muscular’ brain that has more grip on your pain in the long term!
In 2017 when Louis Zantema met Margryt Fennema, he was a psychologist at Medisch Centrum Leeuwarden, where he gave training at the pain outpatient clinic. Together Louis and Margryt saw the possibilities of developing a tool to help more than just these patients, and started to develop their method, together with the patients. Nowadays Louis is the Chief Science Officer at Reducept and he will join us to share the story of Reducept.